CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

September 8, 2026 · Phase 2 readout

ROIV Phase 2 readout: a positive outcome, +18.8%

On September 8, 2026, Roivant Sciences Ltd. reached its Phase 2 readout. The result was a positive outcome, and the stock moved +18.8% in the window around the event.

The move

$34.93
1d before
$41.48
Event day
$41.81
1d after
$40.82
5d after

Pre-catalyst setup

-3.9%
30-day run-up
3473%
30-day volatility
0.7×
volume spike